Each one in plain English, with the numbers worked through for a shareholder.
5 Jan 2024other● Neutral
Monthly CDI statement for December 2023. Quoted CDIs rose from 457.5m to 504.0m, mainly through transfers; PMTAP warrants (8.65m) were exercised and, per the table, option exercises also occurred. Administrative; no operational news.
Step-out holes at CV5 and CV13 returned more lithium results from the summer-fall program, best 56.6 m at 1.37% Li2O at CV5; 27 holes reported, over 125 still awaiting assays. Company will now only announce intercepts alongside assays.
Monthly CDI statement for November 2023. Quoted CDIs rose from 393.0m to 457.5m, mainly through transfers; warrant and option exercises included PMTAP (3.1m) and PMTAL (2.16m). Administrative; no operational news.
Patriot filed its Preliminary Information Statement with the Quebec government, starting the provincial approvals process for Corvette as an open-pit spodumene mine. The federal Project Description is ready but held pending clarity after a Supreme Court of Canada ruling on the Impact Assessment Act.
Company presentation at the Macquarie Western Australia Forum, November 2023. Mostly legal disclaimers and previously announced Corvette information; no new results or figures visible in the text provided.
The 22 November CV9 announcement was reissued with a table of estimated spodumene content (0.1–5% for the key intervals) and cautionary wording. The findings are unchanged. Assays for CV9 are expected in late Q1 2024.
First drilling at CV9, 14 km west of CV5, logged spodumene-bearing pegmatite, including about 100 m in CV23-345; 18 holes (~4,000 m) done. These are visual logs only; no assays yet. A new discovery claimed by the company, with grades unknown.
Unaudited results to 30 September 2023: cash C$133.5m (March: C$56.7m), total assets C$220.4m, equity C$179.6m. Six-month net loss was C$471k, helped by C$9.3m flow-through premium income. Cash reflects the Albemarle placement closed in August.
CV23-199 returned the widest intersection on Corvette to date: 172.4 m at 0.93% Li2O, including 34.5 m at 1.85%. Early assays from the CV5 western extension, outside the resource, are also well mineralised (e.g. 46.3 m at 1.20%). Drilling pauses until early January; over 140 holes await assays.
Monthly CDI statement for October 2023. Quoted CDIs rose from 359.9m to 393.0m, mainly through transfers from ordinary shares; 2.9m PMTAP warrants (C$0.75) were exercised. Administrative; no operational news.
Patriot bought 100% of two claim blocks (73 claims, 3,851.5 ha) next to Alkem's James Bay Lithium Project at Eastmain, for C$500,000 cash plus 120,000 shares. The CEO says non-core assets are being evaluated for value; Corvette remains the focus.
At the ASX's request, the 19 October CV13 announcement was reissued with added detail and a cautionary statement on the 1.3 m spodumene crystal photo (drill hole CV23-271). Drilling results and figures are unchanged.
New near-surface high-grade zone found at CV13, the first CV13 assays this season: best 8.0 m at 2.86% Li2O including 4.3 m at 5.03%, and 12.7 m at 2.46%. Company says this opens starter-pit options; eight rigs active; updated resource expected mid-2024.
Monthly CDI statement for September 2023. Quoted CDIs rose from 351.6m to 359.9m through transfers from ordinary shares, and 146,759 warrants were exercised. Administrative; no operational news.
Bradley Seward (formerly head of critical minerals sales at Macquarie) joins as Vice President of Investor Relations, and Olivier Caza-Lapointe as Head of Investor Relations, North America. The company says this is to improve shareholder communications. No operational impact.
CV5 pegmatite now traced 4.35 km, up from 3.7 km, after a 650 m westward extension; best intersection 56.8 m continuous, with a 178.2 m pegmatite interval in one hole (assays pending). Seven rigs are active, with ten targeted by mid-January 2024. Assays due from October.
All resolutions passed at the 19 September meeting, including re-election of all five directors, the amended incentive plan, and ratification of the earlier flow-through and Albemarle placements. About 45% of shares were voted. Lowest support was 76.9% on the plan (minority vote).
Ahead of the 19 September meeting, the company dropped a share-plan provision for awards bought on market. As a result it cannot use an ASX exemption, so director awards under the plan will need shareholder approval. The plan is otherwise similar to last year's.
The formal technical report supporting the maiden CV5 resource (109.2 Mt at 1.42% Li2O inferred) has been filed, as promised for early September. Prepared by independent BBA Engineering. The resource figures are unchanged from 31 July; this is a filing, not a revision.
Patriot's CDIs will join the S&P/ASX 300 Index from 18 September 2023, as flagged on 1 September. The company says it may bring more Australian institutional demand and liquidity. Index change only; no company transaction or new operating information.
Monthly CDI statement for August 2023. Quoted CDIs rose from 348.4m to 351.6m through transfers, with some option and warrant exercises. Administrative; no operational news.
Third-party index announcement: S&P Dow Jones will add Patriot Battery Metals to the S&P/ASX 300 from 18 September 2023. This is an index change, not a company announcement, and no company transaction is involved.
About 35 holes and 10,100 m drilled this summer, with four rigs rising to seven by mid-September. CEO cites $150m in the treasury. New drill results are deferred until after the CV5 technical report is filed in early September.
Exploration resumed in early August as wildfires eased; four drill rigs are active. The KM-270 camp and all-weather road are due in November, allowing drilling into December, about six weeks later than usual. Road closures still slow construction.
Unaudited quarter to 30 June 2023: cash fell from C$56.7m to C$35.4m, and net loss was C$186,000 after C$4.0m of flow-through premium income offset C$3.2m expenses. Total assets C$105.5m. Excludes the Albemarle money received in August.
The C$109m Albemarle placement has closed, as announced on 31 July. Albemarle holds about 6.4% of shares (4.9% fully diluted) and the investor rights agreement and non-binding MOU are now signed. Shares are restricted from resale for four months.
Monthly CDI statement for July 2023. Quoted CDIs rose from 340.3m to 348.4m, due to transfers from ordinary shares. It also corrects a June warrant count from 825 to 875. Administrative; no operational news.
Notice of an investor conference call on 3 August 2023 to discuss the maiden CV5 resource and the C$109m Albemarle investment. Administrative notice with no new information.
Albemarle agreed to buy 7,128,341 shares at C$15.29 (about C$109m), a 7% premium, for about 6.4% undiluted. Funds go to accelerating Corvette work. A non-binding MOU to study a downstream lithium hydroxide plant, with nine months' exclusivity, was also agreed.
What it means for a shareholder
7.1m new shares at C$15.29 to raise about C$109m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
August 2023 company presentation, the excerpt showing only legal disclaimers and forward-looking warnings. No new results or figures are visible in the text provided; likely repeats the known CV5 resource story.